Denali Advisors LLC lessened its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Rating) by 41.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,800 shares of the company’s stock after selling 2,700 shares during the quarter. Denali Advisors LLC’s holdings […]